Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study. - Wikidata - wikimedia - TriplyDB

Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study.

Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study.

http://www.wikidata.org/entity/Q34411311

about

Inflammatory status in human hepatic cirrhosis The X-factor in primary biliary cirrhosis: monosomy X and xenobiotics Emerging concepts in alcoholic hepatitis Hepatic inflammation and fibrosis: functional links and key pathways.Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment IL-22 in tissue-protective therapy.Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.Recent advancement of molecular mechanisms of liver fibrosis.How Does Interleukin-22 Mediate Liver Regeneration and Prevent Injury and Fibrosis?The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis (Review).Persistently elevated circulating Th22 reversely correlates with prognosis in HBV-related acute-on-chronic liver failure.Interleukin-22 serum levels are a negative prognostic indicator in patients with hepatocellular carcinoma.Does IL-22 protect against liver fibrosis in hepatitis C virus infection?A Protective Function of IL-22BP in Ischemia Reperfusion and Acetaminophen-Induced Liver Injury.Reply: To PMID 21674558.Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases.The role of IL-22 in the resolution of sterile and nonsterile inflammation.Ambiguous roles of innate lymphoid cells in chronic development of liver diseases.The Interleukin-20 Cytokine Family in Liver Disease.

P2860

Q26778040-5A7D5899-55BD-47B8-9BF9-533D29B05609 Q26830032-40FC873F-261B-401E-B496-75FF8DE9E33F Q30234425-9E5AB0CB-8D8A-4BFF-9C93-5F033887AED1 Q35213917-F13CE88B-6C34-455F-B367-C5B2F90628D3 Q36001720-00D26F09-4E58-4AFD-AF0A-5B0AF0FFA02B Q37411315-B5C7DEF9-A97B-4483-A204-BF8A748EF73B Q37673234-5143ECE2-BCF5-4EA6-ABB7-C19A66D343B5 Q38093227-31C3DDE1-D5FB-4E6D-826B-354597E050CD Q38303313-8E1FDD32-C691-4E64-AA43-0DD5F7E13641 Q38419194-1A6DF2B7-1563-4A7A-A52D-C0E9B5FF1F92 Q38775072-71E9A5E3-8BA0-4A0C-B7FE-FD59B613F7E1 Q39450245-1F362159-C7F0-4256-B772-2162365A827E Q40567688-B4BC2CFA-85E4-4786-A81D-F1BC1F0B5012 Q43782860-08F6D886-186E-4721-93A7-9425AE115B8E Q44625945-CE49118B-46BE-4295-A5AD-09B186A5226D Q45874050-DD5A3BF8-30BB-49BC-858F-AADA6C674C8E Q50847600-D03C6B39-A5A0-40C9-B0AD-CE7583CABA85 Q53402699-34B17A7F-C7C1-4616-A095-336BBC24495F Q54224246-AEBFA8B6-90C3-4F07-A012-6588B064EC83 Q55208795-6918CA78-3D4D-4C65-BA73-A86645CEB669 Q55233965-01EE9450-A094-4C5D-BB20-317360A3E9A0

P2860

Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study.

http://www.wikidata.org/entity/Q34411311

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Interleukin-22 predicts severi ...... s: a prospective cohort study.

@ast

Interleukin-22 predicts severi ...... s: a prospective cohort study.

@en

Interleukin-22 predicts severi ...... s: a prospective cohort study.

@nl

type

label

Interleukin-22 predicts severi ...... s: a prospective cohort study.

@ast

Interleukin-22 predicts severi ...... s: a prospective cohort study.

@en

Interleukin-22 predicts severi ...... s: a prospective cohort study.

@nl

prefLabel

Interleukin-22 predicts severi ...... s: a prospective cohort study.

@ast

Interleukin-22 predicts severi ...... s: a prospective cohort study.

@en

Interleukin-22 predicts severi ...... s: a prospective cohort study.

@nl

P1433

Q34411311-B76B0494-F676-456F-9C51-34513E24B65C

P1476

Q34411311-DD8111EE-DAD9-4B3D-B028-DC4BB98C8383

P2093

Q34411311-6C2C5BB5-8907-4D38-9D3B-3000810AD3AE

Q34411311-71627F5B-7CC0-48B7-878E-DAFBA4265ACC

Q34411311-7677270D-D558-4046-A85D-61FE624AF81F

Q34411311-7E6ADC9E-23B4-43BD-995E-3E210489EB95

Q34411311-C0A22A02-A27C-4BA1-871A-06A7A761246C

Q34411311-DE5FFD9F-FC5E-400F-97B2-84ACC21902DC

Q34411311-F4CFB81D-F498-45F8-9722-ECCCAE3B2CEE

P2860

Q34411311-0E31274E-BFA2-47E3-BB25-A1B8A3BF3B05

Q34411311-15C269BF-C245-4596-91DE-242C5D06E25E

Q34411311-17E9AFA3-9706-409F-8471-571F52089C1C

Q34411311-1DB81927-F91C-465A-B3F6-330A1D392E0B

Q34411311-1EDF0C60-59F3-4428-9236-CBA88C474056

Q34411311-2CE9AEAB-2A0A-4FF1-AF4E-45C0D2EF95C3

Q34411311-3278D11E-D1A4-4D61-9EFC-25DA510199AF

Q34411311-3316CD89-F030-4496-A95A-A1726E966D76

Q34411311-343D9E24-12BF-444F-A064-5A81E0450637

Q34411311-453FC416-1922-4351-9138-4D65CA458884

P2888

Q34411311-AD0590BC-8E66-4F8E-B81A-D11D1BBA7B51

P304

Q34411311-778E2AA8-8939-4650-9C94-E9CAB6863D8B

P31

Q34411311-A1599DF8-502D-40C6-88FC-BD8EAE27AF84

P356

Q34411311-28EAA8CE-0A2B-48C0-8A91-AC42AD757160

P407

Q34411311-3A149199-B1B9-4FE4-B5A9-008A319C43DD

P478

Q34411311-20891BA1-4FAD-40A5-A61C-D4E50B3CA47F

P50

Q34411311-0D89AA6D-EF65-4D63-9F04-93C5655916FF

Q34411311-5EAC0983-B3C4-422B-8A18-66F018DC51CB

Q34411311-806D6046-FAC3-4B8E-91EC-320149270444

Q34411311-912519D2-1599-4DAD-985E-46C44A316354

Q34411311-CF952A66-DDC2-41DF-A939-8CF12D80A0AE

P577

Q34411311-7146BCA4-7ECC-4F92-82EE-CBEFF8E8F5AA

P5875

Q34411311-73833BF6-48D7-4348-B4BF-C74F6457F194

P6179

Q34411311-93F68974-48DF-488C-819D-F169A55570DA

P698

Q34411311-A1AF80A4-F146-4BB1-9EBA-80FAD342C61E

P921

Q34411311-4EF1F27C-7A96-4CBD-B902-9FB639F3C91B

P932

Q34411311-51708119-190F-4CD2-AB4D-C020C7BFAEDF

P356

1741-7015-10-102

P1433

P1476

Interleukin-22 predicts severi ...... s: a prospective cohort study.

@en

P2093

Bernd Kronenberger

http://www.w3.org/2001/XMLSchema#string

Eva Herrmann

http://www.w3.org/2001/XMLSchema#string

Friederike Brunner

http://www.w3.org/2001/XMLSchema#string

Josef Pfeilschifter

http://www.w3.org/2001/XMLSchema#string

Lisa Kapper

http://www.w3.org/2001/XMLSchema#string

Malte Bachmann

http://www.w3.org/2001/XMLSchema#string

Oliver Waidmann

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

Biology of interleukin-22.

IL-22 is involved in liver regeneration after hepatectomy

New assessment of hepatic encephalopathy.

IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia.

Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3.

In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression.

A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus.

Expression of interleukin-22 in Sjögren's syndrome: significant correlation with disease parameters

Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation

P2888

1741-7015-10-102

P304

102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1741-7015-10-102

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Natalie Filmann

Albrecht Piiper

P577

2012-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230831757

http://www.w3.org/2001/XMLSchema#string

P6179

1016223015

http://www.w3.org/2001/XMLSchema#string

P698

22967278

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

3519550

http://www.w3.org/2001/XMLSchema#string